NutriBand Inc. Files 8-K for Material Definitive Agreement

TL;DR

NutriBand just signed a big deal, filing an 8-K on 4/19/24. Details to follow.

AI Summary

NutriBand Inc. announced on April 19, 2024, that it entered into a material definitive agreement. The company, incorporated in Nevada with its principal executive offices in Orlando, Florida, filed this 8-K report to disclose this significant event. The filing also includes financial statements and exhibits related to this agreement.

Why It Matters

This filing indicates a significant business development for NutriBand Inc., potentially impacting its operations, financial standing, and future strategic direction.

Risk Assessment

Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the specifics of this agreement are not detailed in the provided text, necessitating further investigation.

Key Players & Entities

• NutriBand Inc. (company) — Filer of the 8-K report
• April 19, 2024 (date) — Date of the earliest event reported
• 121 S. Orange Ave. Suite 1500 Orlando, Florida 32801 (address) — Principal Executive Offices
• 407 377-6695 (phone_number) — Business Phone Number

FAQ

Key Financial Figures

• $8,400,000 — pril 19, 2024, the Company completed an $8,400,000 equity financing with European investor
• $4.00 — ,100,000 units ("Units"), at a price of $4.00 per Unit, each Unit consisting of one s
• $6 — The Warrants have an exercise price of $6.43, are exercisable by payment of the e

Filing Documents

• ea0204490-8k_nutriband.htm (8-K) — 30KB
• ea020449001ex4-19_nutriband.htm (EX-4.19) — 25KB
• ea020449001ex10-32_nutriband.htm (EX-10.32) — 72KB
• 0001213900-24-035276.txt ( ) — 361KB
• ntrb-20240419.xsd (EX-101.SCH) — 3KB
• ntrb-20240419_def.xml (EX-101.DEF) — 26KB
• ntrb-20240419_lab.xml (EX-101.LAB) — 36KB
• ntrb-20240419_pre.xml (EX-101.PRE) — 25KB
• ea0204490-8k_nutriband_htm.xml (XML) — 5KB

01. Entry

Item 1.01. Entry into a Material Definitive Agreement. On April 19, 2024, the Company completed an $8,400,000 equity financing with European investors (the "Offering") of 2,100,000 units ("Units"), at a price of $4.00 per Unit, each Unit consisting of one share of common stock ("Shares") and a Warrant to purchase two Shares of common stock (the "Warrants"). The Warrants have an exercise price of $6.43, are exercisable by payment of the exercise price in cash only and expire April 19, 2029, five years from the date of issuance ("Warrants"). The Offering was made solely to investors resident outside the United States and was not registered under the Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any jurisdiction, including any jurisdiction outside the United States, but was made privately by the Company pursuant to the exemptions from registration provided in the SEC's Regulation S and other exemptions under the Securities Act. The form of subscription agreement entered into with the investors in the Offering and the form of Warrant issued in the financing are filed as Exhibits with this Current Report. The foregoing descriptions of the terms of the Subscription Agreement or of the Warrant are not complete descriptions of these documents and are qualified in their entirety by the full text of each of such agreement, which are attached as Exhibits 10.32 and Exhibit 4.19, respectively, and incorporated by reference herein.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits The following exhibits are being filed with this Current Report on Form 8-K: 4.19 Form of Common Stock Purchase Warrant issued in April 19, 2024 Equity Financing 10.32 Form of Subscription Agreement for April 19, 2024 Equity Financing 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1

SIGNATURES

SIGNATURES PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED. NUTRIBAND, INC. Date: April 23, 2024 By: /s/ Gareth Sheridan R: Gareth Sheridan Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR